Aspartame: A	Sweet Toxin? by Degani, Atara Rena
The Science Journal of the Lander 
College of Arts and Sciences 
Volume 3 
Number 1 Spring 2010 - 
2010 
Aspartame: A Sweet Toxin? 
Atara Rena Degani 
Touro College 
Follow this and additional works at: https://touroscholar.touro.edu/sjlcas 
 Part of the Chemicals and Drugs Commons 
Recommended Citation 
Degani, A. R. (2010). Aspartame: A Sweet Toxin?. The Science Journal of the Lander College of Arts and 
Sciences, 3(1). Retrieved from https://touroscholar.touro.edu/sjlcas/vol3/iss1/4 
This Article is brought to you for free and open access by the Lander College of Arts and Sciences at Touro Scholar. 
It has been accepted for inclusion in The Science Journal of the Lander College of Arts and Sciences by an 















	 Consumers	were	 thrilled	when	 aspartame	was	 introduced	 to	 the	market.	 	 Since	 this	 artificial	
sweetener’s	 safety	was	approved,	 it	has	 found	 its	way	 into	over	6,000	products,	 including	soft	drinks,	
chewing	gum,	hot	chocolate,	candy,	desserts,	sweeteners,	and	yogurt.	Sold	commercially	under	names	
such	 as	 Nutra-Sweet,	 Equal	 and	 Canderel,	 aspartame	 is	 two	 hundred	 times	 sweeter	 than	 sucrose.		





sweetness	when	he	 licked	his	 fingers	 in	 order	 to	pick	 up	 a	weighing	paper.	 	Despite	 its	 unintentional	
discovery,	aspartame	has	had	a	profound	impact	on	the	dieting	habits,	and	it	is	one	of	the	most	widely	
used	artificial	sweeteners	in	the	world	(Sofffritti	et	al.,	2007).	
Aspartame’s	 unique	 formula	 helps	 obese	 maintain	 their	 weight	 loss	 programs	 and	 allows	
diabetics	to	enjoy	exceptional	dishes	within	their	dietary	restrictions	(Butchko	et	al.	2002).		In	the	United	
States,	 the	 acceptable	 daily	 intake	 (ADI)	 of	 aspartame	 is	 50	mg/kg	 body	weight.	 Consumption	 by	 the	







harmfulness	 of	 this	 chemical,	 pointing	 to	 the	 toxic	 nature	 of	 its	 constituents.	 Today	 controversy	 still	
	






describing	 the	 adverse	 health	 affects	 associated	with	 it.	Written	 complaints	 include	 that	 of	 dizziness,	
visual	 impairment,	disorientation,	ear	buzzing,	 tunnel	 vision,	 loss	of	equilibrium,	 severe	muscle	aches,	
numbing	of	extremities,	increased	blood	pressure,	retinal	hemorrhaging	and	depression	(Monte	1984).	













further	 questioned	 when	 the	 research	 conducted	 on	 aspartame	 is	 analyzed.	 	 One	 is	 compelled	 to	
























and	 Wurtman	 1987).	 	 Upon	 ingestion,	 aspartame	 is	 metabolized	 in	 the	 gastric	 tracts	 to	 its	 three	
constituents:	 aspartate,	 phenylalanine,	 and	methanol.	 These	 components	 proceed	 to	 be	 transformed	
into	 other	 products.	 Aspartate	 is	 transformed	 into	 alanine	 and	 oxaloacetate;	 phenylalanine	 is	
transformed	 into	 tyrosine,	 phenylethylamine	 and	 phenylpyruvate,	 and	 methanol	 is	 transformed	 into	
formaldehyde	 which	 later	 forms	 formic	 acid	 (Soffritti	 et	 al.	 2006).	 While	 these	 components	 are	








no-fat	milk	 provides	 13	 times	 as	much	 aspartic	 acid	 as	 a	 beverage	 sweetened	 100%	with	 aspartame	
(Monte	1984).	
While	aspartate	is	not	toxic	when	absorbed,	even	in	large	quantities,	from	natural	foods,	it	may	






	 When	aspartate	 it	 is	absorbed	 in	excess,	 it	can	wreak	significant	damage	on	the	body.	Daabes	
and	co-workers	(1985)	determined	that	plasma	levels	of	aspartate	and	glutamate	which	exceeded	110	








plasma	 aspartate	 levels	 when	 it	 is	 ingested	 in	 conjunction	 with	mono	 sodium	 glutamate	 (MSG).	 The	




and	 pose	 a	 threat	 of	 neurotoxicity	 at	 high	 dosages,	 Olney	 (1982)	 has	 suggested	 that	 consuming	
aspartame	 along	with	 foods	which	 contain	MSG	 leads	 to	 a	 risk	 of	 toxicity	 and	 of	 focal	 brain	 lesions.	
However,	 Stegink	 and	 coworkers	 (1983)	 conducted	numerous	 studies	 and	discovered	 that	while	MSG	








from	 phenylketonuria	 (PKU),	 a	 rare	 genetic	 disease.	 The	 diets	 of	 phenylketonurics	 are	 extremely	
restricted	from	shortly	after	birth	in	order	to	avoid	the	risks	of	mental	retardation	or	various	degrees	of	
cognitive	 impairment	 (Butchko	 et	 al.	 2002).	 	 However,	 phenylalanine	 is	 not	 only	 dangerous	 for	
phenylketonurics;	spikes	in	plasma	phenylalanine	levels	can	be	toxic	due	to	the	body’s	method	of	uptake	
of	this	amino	acid.	
Upon	 ingestion,	 phenylalanine	 is	 absorbed	 across	 the	 gastrointestinal	 mucosa	 into	 portal	
circulation.	Most	dietary	phenylalanine	goes	unchanged	into	systemic	circulation	and	is	taken	up	across	
the	blood-brain	barrier	and	 into	 the	central	nervous	 system	via	a	 transport	 system	 that	 is	 specific	 for	





of	 brain	 catecholamine	 and	 serotonin,	 which,	 in	 turn,	 mediates	 neurological	 changes	 and	 induces	
seizures	(Maher	and	Wurtman	1987).	
Some	 researchers	 suggest	 that	 aspartame	 ingestion	 poses	 a	 risk	 because	 it	 provides	
phenylalanine	without	other	 LNAA.	Consequently,	 upon	being	metabolized	 there	will	 be	 an	 increased	
phenylalanine	uptake	by	the	brain	causing	the	aforementioned	problems	(Maher	and	Wurtman	1987).		
However,	other	scientists,	such	as	Stegink	and	coworkers	(1987),	found	that	this	is	not	the	case.	In	their	
studies,	 they	 found	 that	 the	 changes	 in	 phenylalanine	 LNAA	 in	 normal	 subjects	 was	 no	 greater	 than	
those	 occurring	 under	 normal	 dietary	 conditions.	 This	 idea	 was	 reinforced	 in	 a	 study	 conducted	 by	
Koeppe	and	coworkers	(1991).	In	this	study,	positron	emission	tomography	was	used	in	order	to	observe	
the	 effects	 of	 elevated	 plasma	 phenylalanine	 levels	 after	 the	 consumption	 of	 large	 boluses	 of	







individuals	 have	 reported	 that	 they	 have	 suffered	 from	 neurological	 or	 behavioral	 reactions	 in	
association	with	 aspartame	 consumption,	 a	 symptom	which	 can	be	 linked	 to	 increased	phenylalanine	
levels	 (Maher	and	Wurtman	1987).	Furthermore,	Walton	and	coworkers	 (1993)	 found	 that	 individuals	
with	 a	 history	 of	mood	disorders,	 such	 as	 depression	 and	 bipolar,	 exhibited	 stronger	 symptoms	 after	
consuming	 aspartame.	 They	 hypothesize	 that	 the	 disorders	 are	 exacerbated	 by	 aspartame’s	
phenylalanine	component	which	upsets	the	balance	of	neurotransmitters.	
Another	 concern	 raised	 regarding	 phenylalanine	 is	 its	 ability	 to	 induce	 seizures.	 In	 one	 study,	
mice	were	given	dosages	in	which	phenylalanine	levels	rose	above	tyrosine	levels,	a	phenomenon	which	
will	 occur	 after	 any	 aspartame	 dose	 in	 humans.	 	 Subsequently,	 the	 mice	 were	 introduced	 to	
epileptogenic	 drugs,	 inhaled	 fluorotyl	 or	 electro	 convulsive	 drugs;	 the	 frequency	of	 seizures	 following	
these	 treatments	 was	 greatly	 increased	 due	 to	 increased	 plasma	 phenylalanine	 levels	 (Maher	 and	
Wurtman	 1987).	 Some	 researchers	 disagree	 with	 these	 findings.	 In	 research	 done	 by	 Dailey	 and	
coworkers	 (1989),	acute	oral	doses	of	aspartame,	 ranging	 from	0	–	2500	mg/kg	were	administered	 to	
CD-1	 mice.	 Increases	 in	 phenylalanine	 and	 tyrosine	 and	 modest	 reduction	 in	 brain	 serotonin	 and	 5-
hydroxinol	 acetic	 acid	 were	 observed.	 However,	 these	 changes	 were	 insufficient	 to	 cause	 functional	







aspartame	 (Butchko	 et	 al.	 2002).	 	 Ten	 percent	 of	 aspartame’s	 weight	 is	 absorbed	 as	 methanol.	 This	
chemical	 is	 released	 in	 the	 small	 intestine	 after	 chymotrypsin	 hydrolyzes	 the	 methyl	 group	 of	 the	
dipeptide.	 	 	 It	 is	 transformed	 later	 into	 formaldehyde	 and	 formic	 acid.,	 both	 toxic	 metabolites.	
Absorption	of	methanol	 increases	 if	 it	 is	 ingested	 as	 free	methanol,	 such	 as	 in	 heated	 foods	 and	 soft	
drinks	(Monte	1984).	
	 The	 dangers	 of	 methanol	 consumption	 via	 aspartame	 have	 been	 raised	 over	 the	 years.	
Methanol	does	not	cause	toxicity	when	consumed	in	wines	and	juices	because	of	the	beverages’	natural	
protective	 features.	 For	 instance,	 juices	 and	 wines	 contain	 high	 ethanol	 to	 methanol	 ratios;	 some	
neutral	spirits	contain	200	molecule	of	ethanol	per	molecule	of	methanol	and	orange	juice	contains	0.8	
mg/L	of	methanol	and	380	mg/L	of	ethanol.	This	has	a	protective	effect	since	ethanol	slows	the	rate	of	
methanol	 being	 transformed	 into	 formaldehyde,	 thereby	 allowing	 the	 body	 to	 excrete	 methanol	 in	
breath	and	 in	urine.	 Juices	have	an	added	protection	 since	 they	have	high	osmolality	 and	an	average	
caloric	 density	 of	 500	 kcal/L,	which	 also	 puts	 definite	 limits	 on	 consumption	 level	 rates	 of	methanol.	
34	
	
Since	 aspartame	 is	 not	 limited	 by	 calories	 or	 osmolarity,	 daily	 methanol	 levels	 may	 rise	 to	
unprecedented	levels,	and	may	prove	to	be	a	cumulative	toxin	(Monte	1984).	
	 One	of	the	key	concerns	about	methanol	is	its	production	of	the	methyl	alcohol	syndrome.	This	
toxicity	 is	found	only	 in	humans	because	man	has	 limited	biochemical	pathways	for	detoxification.	For	
twelve	to	eighteen	hours	after	the	methanol	consumption	there	 is	a	 latent	period,	 followed	by	severe	
acidosis	which	is	caused,	in	part,	by	formic	acid	formation.	Patients	complain	of	confusion,	lethargy,	and	
impairment	 of	 articulation,	 and	 may	 also	 suffer	 from	 back	 pain,	 vertigo,	 abdominal	 pain,	 labored	
breathing,	leg	cramps,	and	visual	loss.	There	are	also	fatal	cases	in	which	the	liver	kidney	and	heart	show	
parenchymal	 degeneration	 and	 the	 lungs	 display	 desquamation	 of	 epithelium,	 edema,	 emphysema,	
congestion,	and	bronchial	pneumonia	(Monte	1984).	
	 The	 danger	 of	 methanol	 is	 rooted	 in	 its	 production	 of	 formaldehyde,	 a	 known	 carcinogen.	
Formaldehyde	 has	 been	 proven	 to	 form	 squamous-cell	 carcinomas	 when	 inhaled	 by	 experimental	
animals.	 It	 reacts	with	DNA	 causing	 irreversible	 denaturation	 and	 can	 interfere	with	DNA	 replication,	
thus	 causing	mutations	 (Monte	1984).	 Studies	have	 verified	 that	 formaldehyde	accumulates	 after	 the	
consumption	 of	 aspartame.	 Trocho	 and	 coworkers	 (1998)	 synthesized	 aspartame	 using	 a	 methanol	
group	 which	 had	 radioactive	 C-14	 and	 fed	 it	 to	 mice.	 They	 later	 found	 that	 the	 methanol	 had	
accumulated	 in	 plasma	 and	 in	 the	 liver,	 and	was	 bound	 to	 protein,	 thus	 determining	 that	 aspartame	












lesions	 of	 the	 renal	 pelvis	 and	 ureter.	 	 Since	 rodents	 have	 been	 found	 to	 be	 consistent	 predictors	 of	
human	 cancer	 risks,	 they	 conclude	 that	 aspartame	 is	 a	multipotential	 carcinogenic	 compound	whose	
carcinogenic	effects	are	evident	even	at	daily	dose	of	20	mg/kg	bw.	
	 Despite	 the	 compelling	 evidence,	 some	 researchers	 do	 not	 believe	 that	 methanol	 will	 cause	
toxicity	in	humans	when	ingested	in	the	form	of	aspartame.	They	assert	that	the	alcohol	is	absorbed	in	











neuronal	 necrosis	 and	 endocrine	 disorders.	 A	 large	 group	 of	 scientists	 believe	 that	 the	 ingestion	 of	
aspartame	can	lead	to	dangerous	spikes	in	aspartate	plasma	levels	when	eaten	in	conjunction	with	MSG,	
while	many	others	believe	that	such	a	spike	is	impossible.	
The	 debate	 about	 phenylalanine’s	 toxicity	 revolves	 around	 the	 ability	 of	 this	 amino	 acid	 to	
interfere	with	 LNAA	at	 the	blood-brain	 barrier.	 Some	 researchers	 are	 concerned	 that	 this	 constituent	
can	 exacerbate	 mood	 disorders	 and	 induce	 seizures.	 However,	 the	 issue	 is	 still	 debated,	 and	 many	
scientists	have	determined	that	aspartame’s	phenylalanine	will	not	cause	adverse	effects.	
Methanol	 consumption	 has	 raised	 significant	 concerns	 since	 this	 alcohol	 is	 metabolized	 as	
formaldehyde,	 a	 known	 toxin.	 Long-term	 studies	 have	 proven	 that	 the	 methanol	 component	 of	





claim	 that	 the	 negative	 studies	 on	 lab	 animals	 are	 run	with	 high	 concentration	 of	 materials	 that	will	
never	be	present	during	normal	 consumption.	 	On	 the	other	hand,	 the	anti-aspartame	camp	believes	
that	the	fast	digestion	of	aspartame	leads	to	the	concentration	of	 its	constituents	in	the	body,	causing	
toxic	 effects.	 Clearly,	 more	 research	 must	 be	 conducted	 on	 the	 subject	 in	 order	 to	 conclusively	
determine	whether	aspartame	is	harmful	or	not.	In	the	interim,	it	would	be	advisable	that	people	who	
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